The short comparison
Investigate the rare-earth chain.
A curated dataset of companies, facilities, output and disclosed relationships, with evidence, comparisons, saved investigations and assumption-based scenarios.
Published offering
interos.ai describes supply-chain risk intelligence using AI-supported insights to uncover and rank risks across extended supplier networks. Its public offering is oriented towards enterprise risk decisions. Public positioning does not establish the detailed rare-earth facility coverage or configuration a specific buyer would receive.
Provider source ↗Is the required output a prioritised supplier list or an evidence-backed material case?
Risk ranking can help a large organisation decide where to focus attention. A specialist analyst also needs to understand the claim behind the ranking: which operation, product, period and relationship makes the supplier relevant? A score is useful when it leads to evidence and action, not when it substitutes for them.
For rare-earth sourcing, ask each vendor to explain a shared-processing dependency between two apparent alternatives. Then distinguish corporate ownership, a reported commercial relationship and an actual physical route. These relationships can all matter, but combining them without explanation can produce an unjustified impression of certainty.
How the work differs
Use Oreline to follow documented facility connections, inspect company ownership and open production or agreement records. Test an explicit disruption assumption, then review the limitations alongside the result. The point is to make the reasoning available to the analyst, not to supply a universal supplier-risk score.
Sources, reporting periods and evidence gaps remain visible throughout the investigation. Coverage is reviewed rather than exhaustive or live, and undisclosed quantities stay unknown. Read how the analysis handles them.
Why Oreline for this work
A prioritised supplier list still leaves the analyst needing to explain the material exposure. Oreline provides a focused workspace for that investigation, with sources and assumptions available to challenge. Start in the sandbox to follow a dependency and inspect the basis for the conclusion.
Pricing and access
Oreline costs $1,000 USD per organisation per month, including 20 individual seats and access to the published research library, curated dataset and investigation tools. See the subscription details.
interos.ai pricing is not quoted here. When comparing costs, account for the required modules, team access, data rights and contract term. Oreline's organisation plan includes the published research and working tools in one subscription.
Oreline’s free sandbox needs no account and contains selected examples. It is a product evaluation, not free access to the full subscription workspace.
What to test before buying
- Ask to trace a risk finding back to its supporting entities and evidence.
- Check whether ownership, trade and physical supply are distinguished.
- Verify relevant supplier coverage and implementation requirements in the demonstration.
Frequently asked questions
Does Oreline assign a universal risk rating to every supplier?
No. Its research and scenario outputs need to be interpreted in the context of the user's question and the available evidence.
How can my team challenge an Oreline scenario?
Inspect the covered connections, source evidence and selected assumptions. A scenario describes consequences within that model; it is not a prediction of outage probability or a measurement of undisclosed flows.
Sources and scope
Provider information checked on . Product descriptions are attributed to the provider; recommendations are Oreline’s assessment of workflow fit. An unmentioned feature is not evidence that the provider lacks it.
- interos.ai risk intelligence solutions
- Oreline’s product, team and subscription scope
- Our comparison and corrections policy
Spotted a changed feature or an error? Send the relevant source to support@sirca.io.
Test the work, not just the description.
Follow a dependency, inspect production evidence and challenge a supplier assumption.
Explore Oreline →